{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:48:50Z","timestamp":1787316530965,"version":"build-2736575974"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,11,10]],"date-time":"2011-11-10T00:00:00Z","timestamp":1320883200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1752-1947-5-548","type":"journal-article","created":{"date-parts":[[2012,1,17]],"date-time":"2012-01-17T14:22:21Z","timestamp":1326810141000},"source":"Crossref","is-referenced-by-count":14,"title":["Reversible cerebral vasoconstriction syndrome in a patient taking citalopram and Hydroxycut: a case report"],"prefix":"10.1186","volume":"5","author":[{"given":"Gregory L","family":"Cvetanovich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankajavalli","family":"Ramakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua P","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram R","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan H","family":"Ropper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,10]]},"reference":[{"issue":"1","key":"1940_CR1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.7326\/0003-4819-146-1-200701020-00007","volume":"146","author":"LH Calabrese","year":"2007","unstructured":"Calabrese LH, Dodick DW, Schwedt TJ, Singhal AB: Narrative review: reversible cerebral vasoconstriction syndromes. Ann Intern Med. 2007, 146 (1): 34-44.","journal-title":"Ann Intern Med"},{"issue":"1","key":"1940_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1385\/NCC:3:1:091","volume":"3","author":"AB Singhal","year":"2005","unstructured":"Singhal AB, Bernstein RA: Postpartum angiopathy and other cerebral vasoconstriction syndromes. Neurocrit Care. 2005, 3 (1): 91-97. 10.1385\/NCC:3:1:091.","journal-title":"Neurocrit Care"},{"issue":"8","key":"1940_CR3","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1212\/01.WNL.0000120669.85649.77","volume":"62","author":"SR Lu","year":"2004","unstructured":"Lu SR, Liao YC, Fuh JL, Lirng JF, Wang SJ: Nimodipine for treatment of primary thunderclap headache. Neurology. 2004, 62 (8): 1414-1416.","journal-title":"Neurology"},{"issue":"3","key":"1940_CR4","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1046\/j.1468-2982.2003.00506.x","volume":"23","author":"DW Dodick","year":"2003","unstructured":"Dodick DW: Reversible segmental cerebral vasoconstriction (Call-Fleming syndrome): the role of calcium antagonists. Cephalalgia. 2003, 23 (3): 163-165. 10.1046\/j.1468-2982.2003.00506.x.","journal-title":"Cephalalgia"},{"issue":"3","key":"1940_CR5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1001\/archneur.61.3.411","volume":"61","author":"AB Singhal","year":"2004","unstructured":"Singhal AB: Postpartum angiopathy with reversible posterior leukoencephalopathy. Arch Neurol. 2004, 61 (3): 411-416. 10.1001\/archneur.61.3.411.","journal-title":"Arch Neurol"},{"issue":"6","key":"1940_CR6","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/art.10797","volume":"47","author":"RA Hajj-Ali","year":"2002","unstructured":"Hajj-Ali RA, Furlan A, Abou-Chebel A, Calabrese LH: Benign angiopathy of the central nervous system: cohort of 16 patients with clinical course and long-term followup. Arthritis Rheum. 2002, 47 (6): 662-669. 10.1002\/art.10797.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1940_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1212\/01.wnl.0000223648.76430.27","volume":"67","author":"O Noskin","year":"2006","unstructured":"Noskin O, Jafarimojarrad E, Libman RB, Nelson JL: Diffuse cerebral vasoconstriction (Call-Fleming syndrome) and stroke associated with antidepressants. Neurology. 2006, 67 (1): 159-160. 10.1212\/01.wnl.0000223648.76430.27.","journal-title":"Neurology"},{"issue":"4","key":"1940_CR8","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s10194-009-0117-3","volume":"10","author":"O Oz","year":"2009","unstructured":"Oz O, Demirkaya S, Bek S, Eroglu E, Ulas UH, Odabasi Z: Reversible cerebral vasoconstriction syndrome: case report. J Headache Pain. 2009, 10 (4): 295-298. 10.1007\/s10194-009-0117-3.","journal-title":"J Headache Pain"},{"issue":"5","key":"1940_CR9","first-page":"737","volume":"83","author":"HP Forman","year":"1989","unstructured":"Forman HP, Levin S, Stewart B, Patel M, Feinstein S: Cerebral vasculitis and hemorrhage in an adolescent taking diet pills containing phenylpropanolamine: case report and review of literature. Pediatrics. 1989, 83 (5): 737-741.","journal-title":"Pediatrics"},{"key":"1940_CR10","unstructured":"FDA Warns Consumers to Stop Using Hydroxycut Products Risk of Liver Injury. \n                    http:\/\/www.fda.gov\/downloads\/NewsEvents\/PublicHealthFocus\/UCM155660.pdf"},{"issue":"14","key":"1940_CR11","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.3748\/wjg.15.1786","volume":"15","author":"A Lobb","year":"2009","unstructured":"Lobb A: Hepatoxicity associated with weight-loss supplements: a case for better post-marketing surveillance. World J Gastroenterol. 2009, 15 (14): 1786-1787. 10.3748\/wjg.15.1786.","journal-title":"World J Gastroenterol"},{"key":"1940_CR12","unstructured":"Sales of Supplements Containing Ephedrine Alkaloids (Ephedra) Prohibited. \n                    http:\/\/web.archive.org\/web\/20080126150250\/www.fda.gov\/oc\/initiatives\/ephedra\/february2004\/"},{"issue":"7","key":"1940_CR13","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1038\/ajg.2010.5","volume":"105","author":"TL Fong","year":"2010","unstructured":"Fong TL, Klontz KC, Canas-Coto A, Casper SJ, Durazo FA, Davern TJ, Hayashi P, Lee WM, Seeff LB: Hepatotoxicity due to hydroxycut: a case series. Am J Gastroenterol. 2010, 105 (7): 1561-1566. 10.1038\/ajg.2010.5.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"1940_CR14","doi-asserted-by":"publisher","first-page":"142","DOI":"10.2146\/ajhp070640","volume":"66","author":"S Dehoney","year":"2009","unstructured":"Dehoney S, Wellein M: Rhabdomyolysis associated with the nutritional supplement Hydroxycut. Am J Health Syst Pharm. 2009, 66 (2): 142-148. 10.2146\/ajhp070640.","journal-title":"Am J Health Syst Pharm"},{"issue":"3","key":"1940_CR15","first-page":"82","volume":"8","author":"SL Willis","year":"2006","unstructured":"Willis SL, Moawad FJ, Hartzell JD, Iglesias M, Jackson WL: Hypertensive retinopathy associated with use of the ephedra-free weight-loss herbal supplement Hydroxycut. MedGenMed. 2006, 8 (3): 82-","journal-title":"MedGenMed"},{"key":"1940_CR16","unstructured":"FDA Warning on Hydroxycut Products. \n                    http:\/\/www.fda.gov\/ForConsumers\/ConsumerUpdates\/ucm152152.htm"},{"key":"1940_CR17","unstructured":"Hydroxycut ingredient list. \n                    http:\/\/www.hydroxycutadvanced.com\/"},{"issue":"10","key":"1940_CR18","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.1002\/hbm.20732","volume":"30","author":"MA Addicott","year":"2009","unstructured":"Addicott MA, Yang LL, Peiffer AM, Burnett LR, Burdette JH, Chen MY, Hayasaka S, Kraft RA, Maldjian JA, Laurienti PJ: The effect of daily caffeine use on cerebral blood flow: How much caffeine can we tolerate?. Hum Brain Mapp. 2009, 30 (10): 3102-3114. 10.1002\/hbm.20732.","journal-title":"Hum Brain Mapp"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1752-1947-5-548\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-5-548.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-5-548","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-5-548.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T03:21:25Z","timestamp":1548127285000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/1752-1947-5-548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,10]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1940"],"URL":"https:\/\/doi.org\/10.1186\/1752-1947-5-548","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,10]]},"article-number":"548"}}